S&P 500   4,283.93 (-0.10%)
DOW   33,404.93 (-0.31%)
QQQ   362.50 (+1.18%)
AAPL   174.10 (+1.69%)
MSFT   321.01 (+1.67%)
META   306.91 (+2.23%)
GOOGL   134.31 (+2.64%)
AMZN   130.34 (+2.53%)
TSLA   253.74 (+1.41%)
NVDA   451.44 (+3.78%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   103.17 (+0.34%)
T   14.89 (-0.87%)
F   12.35 (-0.56%)
MU   68.09 (+0.09%)
CGC   0.80 (+2.13%)
GE   109.62 (-0.84%)
DIS   81.33 (+0.35%)
AMC   8.00 (+0.13%)
PFE   33.38 (+0.63%)
PYPL   59.01 (+0.94%)
NFLX   384.03 (+1.70%)
S&P 500   4,283.93 (-0.10%)
DOW   33,404.93 (-0.31%)
QQQ   362.50 (+1.18%)
AAPL   174.10 (+1.69%)
MSFT   321.01 (+1.67%)
META   306.91 (+2.23%)
GOOGL   134.31 (+2.64%)
AMZN   130.34 (+2.53%)
TSLA   253.74 (+1.41%)
NVDA   451.44 (+3.78%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   103.17 (+0.34%)
T   14.89 (-0.87%)
F   12.35 (-0.56%)
MU   68.09 (+0.09%)
CGC   0.80 (+2.13%)
GE   109.62 (-0.84%)
DIS   81.33 (+0.35%)
AMC   8.00 (+0.13%)
PFE   33.38 (+0.63%)
PYPL   59.01 (+0.94%)
NFLX   384.03 (+1.70%)
S&P 500   4,283.93 (-0.10%)
DOW   33,404.93 (-0.31%)
QQQ   362.50 (+1.18%)
AAPL   174.10 (+1.69%)
MSFT   321.01 (+1.67%)
META   306.91 (+2.23%)
GOOGL   134.31 (+2.64%)
AMZN   130.34 (+2.53%)
TSLA   253.74 (+1.41%)
NVDA   451.44 (+3.78%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   103.17 (+0.34%)
T   14.89 (-0.87%)
F   12.35 (-0.56%)
MU   68.09 (+0.09%)
CGC   0.80 (+2.13%)
GE   109.62 (-0.84%)
DIS   81.33 (+0.35%)
AMC   8.00 (+0.13%)
PFE   33.38 (+0.63%)
PYPL   59.01 (+0.94%)
NFLX   384.03 (+1.70%)
S&P 500   4,283.93 (-0.10%)
DOW   33,404.93 (-0.31%)
QQQ   362.50 (+1.18%)
AAPL   174.10 (+1.69%)
MSFT   321.01 (+1.67%)
META   306.91 (+2.23%)
GOOGL   134.31 (+2.64%)
AMZN   130.34 (+2.53%)
TSLA   253.74 (+1.41%)
NVDA   451.44 (+3.78%)
NIO   8.83 (-2.32%)
BABA   86.51 (-0.27%)
AMD   103.17 (+0.34%)
T   14.89 (-0.87%)
F   12.35 (-0.56%)
MU   68.09 (+0.09%)
CGC   0.80 (+2.13%)
GE   109.62 (-0.84%)
DIS   81.33 (+0.35%)
AMC   8.00 (+0.13%)
PFE   33.38 (+0.63%)
PYPL   59.01 (+0.94%)
NFLX   384.03 (+1.70%)

Sabra Health Care REIT (SBRA) Stock Forecast, Price & News

$13.78
-0.16 (-1.15%)
(As of 11:22 AM ET)
Compare
Today's Range
$13.70
$14.03
50-Day Range
$11.81
$14.06
52-Week Range
$10.08
$14.32
Volume
522,568 shs
Average Volume
2.17 million shs
Market Capitalization
$3.19 billion
P/E Ratio
N/A
Dividend Yield
8.71%
Price Target
$13.35

Sabra Health Care REIT MarketRank™ Forecast

Analyst Rating
Hold
2.11 Rating Score
Upside/​Downside
4.2% Downside
$13.35 Price Target
Short Interest
Bearish
6.75% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
1.56mentions of Sabra Health Care REIT in the last 14 days
Based on 7 Articles This Week
Insider Trading
Acquiring Shares
$24,591 Bought Last Quarter
Proj. Earnings Growth
5.30%
From $1.32 to $1.39 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.56 out of 5 stars

Finance Sector

815th out of 879 stocks

Real Estate Investment Trusts Industry

169th out of 183 stocks


SBRA stock logo

About Sabra Health Care REIT (NASDAQ:SBRA) Stock

As of June 30, 2023, Sabra's investment portfolio included 392 real estate properties held for investment (consisting of (i) 253 Skilled Nursing/Transitional Care facilities, (ii) 45 senior housing communities (Senior Housing Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 13 investments in loans receivable (consisting of two mortgage loans and 11 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of June 30, 2023, Sabra's real estate properties held for investment included 38,899 beds/units, spread across the United States and Canada.

SBRA Price History

SBRA Stock News Headlines

Nursing Home REITs: The Surprise Heroes of High Yield Investing
Income seekers are finding value and yield in nursing home REITs Omega, Sabra and LTC Properties, as they offer stable dividends and tax benefits.
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Sabra Health Care REIT (NASDAQ:SBRA) Hits New 1-Year High at $14.17
Gold Could Be Heading for Record Highs - But How to Play It?
According to FX Empire, the gold forecast is now bullish, with support for a $3,000 target in 2024. The big question is how to play it. Some investors are discovering a unique gold investment alternative that sidesteps the major issues with gold mining stocks or physical gold.
Where Sabra Health Care REIT Stands With Analysts
Sabra Health Care: A 9% Yielding Healthcare REIT
Wells Fargo Keeps Their Sell Rating on Sabra Healthcare REIT (SBRA)
Sabra Reports Second Quarter 2023 Results
Sabra Health Care REIT earnings: here's what to expect
Sabra Publishes Third Annual Sustainability Report
3 REITs To Sell Before They Do Your Portfolio In
Expert Ratings for Sabra Health Care REIT
See More Headlines
Receive SBRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sabra Health Care REIT and its competitors with MarketBeat's FREE daily newsletter.

SBRA Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 8/31 Dividend
8/16/2023
Dividend Payable
8/31/2023
Today
10/02/2023
Next Earnings (Estimated)
11/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
Specialized REITs
Sector
Finance
Current Symbol
NASDAQ:SBRA
CUSIP
78573L10
Employees
42
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$13.35
High Stock Price Forecast
$15.00
Low Stock Price Forecast
$11.00
Forecasted Upside/Downside
-4.2%
Consensus Rating
Hold
Rating Score (0-4)
2.11
Research Coverage
9 Analysts

Profitability

Net Income
$-77,610,000.00
Pretax Margin
-4.36%

Debt

Sales & Book Value

Annual Sales
$624.81 million
Cash Flow
$0.48 per share
Book Value
$13.23 per share

Miscellaneous

Free Float
228,907,000
Market Cap
$3.22 billion
Optionable
Optionable
Beta
1.29

Social Links

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Key Executives

  • Mr. Richard K. Matros (Age 69)
    Chairman, Pres & CEO
    Comp: $2.52M
  • Mr. Michael Lourenco Costa (Age 44)
    Exec. VP, CFO, Principal Accounting Officer & Sec.
    Comp: $799.16k
  • Ms. Talya Nevo-Hacohen (Age 63)
    Exec. VP, Chief Investment Officer & Treasurer
    Comp: $1.32M
  • Mr. Harold W. Andrews Jr.Mr. Harold W. Andrews Jr. (Age 59)
    Consultant
  • Mr. Peter W. Nyland
    Exec. VP of Asset Management
  • Mr. Darrin L. Smith
    Exec. VP of Investments
  • Mr. Lukas Michael Hartwich C.F.A.
    Sr. VP of Fin.
  • Ms. Eliza Gozar
    Sr. VP of Investments
  • Ms. Jessica Flores
    Sr. VP of Fin. & Controller













SBRA Stock - Frequently Asked Questions

Should I buy or sell Sabra Health Care REIT stock right now?

9 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sabra Health Care REIT in the last year. There are currently 1 sell rating, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" SBRA shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SBRA, but not buy additional shares or sell existing shares.
View SBRA analyst ratings
or view top-rated stocks.

What is Sabra Health Care REIT's stock price forecast for 2023?

9 brokerages have issued 1 year price targets for Sabra Health Care REIT's shares. Their SBRA share price forecasts range from $11.00 to $15.00. On average, they expect the company's stock price to reach $13.35 in the next twelve months. This suggests that the stock has a possible downside of 4.2%.
View analysts price targets for SBRA
or view top-rated stocks among Wall Street analysts.

How have SBRA shares performed in 2023?

Sabra Health Care REIT's stock was trading at $12.43 at the start of the year. Since then, SBRA stock has increased by 12.1% and is now trading at $13.94.
View the best growth stocks for 2023 here
.

When is Sabra Health Care REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 6th 2023.
View our SBRA earnings forecast
.

How were Sabra Health Care REIT's earnings last quarter?

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) posted its quarterly earnings data on Wednesday, May, 4th. The real estate investment trust reported $0.18 EPS for the quarter, topping analysts' consensus estimates of $0.17 by $0.01. Sabra Health Care REIT had a negative net margin of 19.63% and a negative trailing twelve-month return on equity of 4.05%. During the same period last year, the business earned $0.39 EPS.

How often does Sabra Health Care REIT pay dividends? What is the dividend yield for Sabra Health Care REIT?

Sabra Health Care REIT declared a quarterly dividend on Monday, August 7th. Stockholders of record on Thursday, August 17th will be paid a dividend of $0.30 per share on Thursday, August 31st. This represents a $1.20 annualized dividend and a dividend yield of 8.61%. The ex-dividend date of this dividend is Wednesday, August 16th.
Read our dividend analysis for SBRA
.

Is Sabra Health Care REIT a good dividend stock?

Sabra Health Care REIT (NASDAQ:SBRA) pays an annual dividend of $1.20 per share and currently has a dividend yield of 8.61%. SBRA has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer.
Read our dividend analysis for SBRA.

What other stocks do shareholders of Sabra Health Care REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sabra Health Care REIT investors own include AT&T (T), Omega Healthcare Investors (OHI), Realty Income (O), Medical Properties Trust (MPW), Energy Transfer (ET), Verizon Communications (VZ), Bank of America (BAC), Annaly Capital Management (NLY), Ventas (VTR) and New Residential Investment (NRZ).

What is Sabra Health Care REIT's stock symbol?

Sabra Health Care REIT trades on the NASDAQ under the ticker symbol "SBRA."

How do I buy shares of Sabra Health Care REIT?

Shares of SBRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sabra Health Care REIT's stock price today?

One share of SBRA stock can currently be purchased for approximately $13.94.

How much money does Sabra Health Care REIT make?

Sabra Health Care REIT (NASDAQ:SBRA) has a market capitalization of $3.22 billion and generates $624.81 million in revenue each year. The real estate investment trust earns $-77,610,000.00 in net income (profit) each year or ($0.54) on an earnings per share basis.

How can I contact Sabra Health Care REIT?

Sabra Health Care REIT's mailing address is 18500 VON KARMAN AVENUE SUITE 550, IRVINE CA, 92612. The official website for the company is www.sabrahealth.com. The real estate investment trust can be reached via phone at (888) 393-8248, via email at investorrelations@sabrahealth.com, or via fax at 949-679-8868.

This page (NASDAQ:SBRA) was last updated on 10/2/2023 by MarketBeat.com Staff

My Account -